Issue 9, 1992

Isomerization of antitumour bicyclic hexapeptide, RA-VII from Rubia Cordifolia. Part 4. Conformation–antitumour activity relationship

Abstract

A bicyclic hexapeptide, RA-VII, isolated from Rubia cordifolia, has been isomerized under basic conditions to give four derivatives (compounds 14). In compounds 1 and 2, both Tyr-5 and -3 residues were isomerized to give an energetically more favourable alternate D and L amino acid peptide sequence and in compounds 3 and 4, a Tyr-5 residue was isomerized. Conformational analyses of compounds 14 in solid and solution states were conducted by X-ray and NMR analysis. The N-methyl amide bond between D-Tyr-5 and Tyr-6 is trans in compounds 14. The geometry of the amide bond on the turn at residues 2 and 3, which is considered to play an important role in the antitumour activity, was found to be trans in compounds 1 and 2, and cis in compounds 3 and 4. Compounds 3 and 4 shows antitumour activities. The conformation of the cis N-methyl amide bond between residues 2 and 3 is shown to play an important role in the antitumour activities of RAs.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 2, 1992, 1635-1642

Isomerization of antitumour bicyclic hexapeptide, RA-VII from Rubia Cordifolia. Part 4. Conformation–antitumour activity relationship

H. Itokawa, H. Morita, K. Kondo, Y. Hitotsuyanagi, K. Takeya and Y. Iitaka, J. Chem. Soc., Perkin Trans. 2, 1992, 1635 DOI: 10.1039/P29920001635

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements